February 12, 2014
A California federal judge on Wednesday allowed Avanir Pharmaceuticals Inc.'s shareholder vote on issues like executive pay to proceed despite the objections of a putative class of investors claiming that its proxy notice was misleading, ruling all the information required for an informed vote was in the notice.
January 17, 2014
Avanir Pharmaceuticals Inc. was hit with a proposed class action Tuesday accusing the firm of misleading investors ahead of a shareholder vote that it could give out tax-deductible performance executive compensation awards despite allegedly being ineligible for such deductions since 2011.